Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 13 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 37 most recent Form 4 transactions.
| May 1 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 900 | $82.60 | $74.3K | -0.5% | Open the original filing on SEC.gov |
| May 1 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 811 | $81.02 | $65.7K | -0.5% | Open the original filing on SEC.gov |
| Apr 16 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 2,000 | $90.00 | $180K | -1.1% | Open the original filing on SEC.gov |
| Apr 1 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,100 | $85.46 | $94K | -0.6% | Open the original filing on SEC.gov |
| Apr 1 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 900 | $84.46 | $76K | -0.5% | Open the original filing on SEC.gov |
| Mar 25 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 2,000 | $85.00 | $170K | -1.1% | Open the original filing on SEC.gov |
| Mar 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 406 | $71.66 | $29.1K | -0.2% | Open the original filing on SEC.gov |
| Mar 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 994 | $70.45 | $70K | -0.5% | Open the original filing on SEC.gov |
| Mar 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 300 | $69.43 | $20.8K | -0.2% | Open the original filing on SEC.gov |
| Mar 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 300 | $68.27 | $20.5K | -0.2% | Open the original filing on SEC.gov |
| Feb 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 100 | $66.89 | $6.7K | <0.1% | Open the original filing on SEC.gov |
| Feb 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,108 | $66.15 | $73.3K | -0.6% | Open the original filing on SEC.gov |
| Feb 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 792 | $65.21 | $51.6K | -0.4% | Open the original filing on SEC.gov |
| Jan 6 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 2,000 | $80.00 | $160K | -1.1% | Open the original filing on SEC.gov |
| Jan 2 | APGE | Apogee Therapeutics, Inc. | AGRANT◷◆ | 83,690 | — | — | — | Open the original filing on SEC.gov |
| Jan 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 4,080 | $75.20 | $306.8K | -2.1% | Open the original filing on SEC.gov |
| Jan 2 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,920 | $74.13 | $142.3K | -1.0% | Open the original filing on SEC.gov |
| Dec 19, 2025 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,500 | $80.00 | $120K | -0.8% | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 11,797 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 13,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS◆ | 26,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 9, 2025 | AKRO | Akero Therapeutics, Inc. | DTOISS | 9,398 | — | — | -100.0% | Open the original filing on SEC.gov |
| Dec 4, 2025 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,500 | $75.00 | $112.5K | -0.8% | Open the original filing on SEC.gov |
| Nov 25, 2025 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,500 | $70.00 | $105K | -0.8% | Open the original filing on SEC.gov |
| Nov 14, 2025 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 2,000 | $65.00 | $130K | -1.0% | Open the original filing on SEC.gov |
| Nov 11, 2025 | APGE | Apogee Therapeutics, Inc. | SSELL◷ | 1,000 | $60.00 | $60K | -0.5% | Open the original filing on SEC.gov |
| Aug 19, 2025 | CRGX | CARGO Therapeutics, Inc. | DTOISS◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 12, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 12, 2025 | AKRO | Akero Therapeutics, Inc. | SSELL | 3,000 | $47.46 | $142.4K | -24.2% | Open the original filing on SEC.gov |
| Aug 12, 2025 | AKRO | Akero Therapeutics, Inc. | MEXER | 3,000 | $7.01 | $21K | +31.9% | Open the original filing on SEC.gov |
| Jun 18, 2025 | CRGX | CARGO Therapeutics, Inc. | AGRANT◆ | 25,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 3, 2025 | AKRO | Akero Therapeutics, Inc. | AGRANT | 9,398 | — | — | — | Open the original filing on SEC.gov |